Nicholson, Robert Ian, Staka, C., Boyns, Frances Elizabeth, Hutcheson, Iain Robert and Gee, Julia Margaret Wendy ![]() |
Abstract
There is an increasing body of evidence demonstrating that elevated growth signaling in breast cancer cells can promote forms of endocrine resistance in either an estrogen receptor-dependent or -independent manner. The current article reviews what is known about such growth factor signaling networks and resistance to estrogen withdrawal and considers the many novel therapeutic opportunities that stem from this knowledge.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology |
Publisher: | Society for Endocrinology |
ISSN: | 1351-0088 |
Last Modified: | 18 Oct 2022 14:18 |
URI: | https://orca.cardiff.ac.uk/id/eprint/17105 |
Citation Data
Cited 88 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
![]() |
Edit Item |